LifeTech Scientific (STU:81X) Total Liabilities : €186.9 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LifeTech Scientific Total Liabilities?

LifeTech Scientific's Total Liabilities for the quarter that ended in Dec. 2024 was €186.9 Mil.

LifeTech Scientific's quarterly Total Liabilities increased from Dec. 2023 (€176.25 Mil) to Jun. 2024 (€183.03 Mil) and increased from Jun. 2024 (€183.03 Mil) to Dec. 2024 (€186.91 Mil).

LifeTech Scientific's annual Total Liabilities increased from Dec. 2022 (€104.13 Mil) to Dec. 2023 (€176.25 Mil) and increased from Dec. 2023 (€176.25 Mil) to Dec. 2024 (€186.91 Mil).

LifeTech Scientific Total Liabilities Historical Data

The historical data trend for LifeTech Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Total Liabilities Chart

LifeTech Scientific Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

74.93

90.82

104.13

176.25

186.91

LifeTech Scientific Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															104.13	106.39	176.25	183.03	186.91

LifeTech Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LifeTech Scientific's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	106.986	+	(0.156	+	79.767
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	186.9

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	642.776	-	455.868
	=	186.9

LifeTech Scientific's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	106.986	+	(0.156	+	79.767
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	186.9

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	642.776	-	455.868
	=	186.9

LifeTech Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeTech Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (STU:81X) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

01302:Hong Kong

Address

No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063

Website

http://www.lifetechmed.com

LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

LifeTech Scientific Headlines

No Headlines